A Longitudinal Observational Follow-up of the PRECEPT Study Cohort (PostCEPT)

Parkinson Study Group (PSG)

Status: Unknown

Conditions: Parkinson Disease

Study type: Observational

Funder types: Other; NETWORK; Industry; Other U.S. Federal agency; NIH

Identifiers

NCT00605163

U01NS050095_PostCEPT

NINDS 5 U01NS050095-02

U01NS050095 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to longitudinally follow consenting clinical trial participants who participated in PRECEPT (A Randomized, Double Blind, Placebo Controlled, Dose Finding Study to Assess the Efficacy and Safety of CEP 1347 in Patients With Early Parkinson's Disease). The study will assess the clinical and imaging outcomes relevant to the natural history of Parkinson's disease (PD), as well as determine early biomarkers of the disease.

Enrollment: 530 estimated patients

Sex: All

Ages: 30+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participation in the PRECEPT study
• Willing and able to give informed consent

Exclusion criteria

• Patients will be excluded from participating in the the study if either of the criteria stated above is not met